Frank Rimerman Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $469K | Sell |
5,994
-240
| -4% | -$18.8K | 0.03% | 363 |
|
|
2025
Q1 | $452K | Sell |
6,234
-532
| -8% | -$38.6K | 0.04% | 333 |
|
|
2024
Q4 | $501K | Buy |
6,766
+1,392
| +26% | +$103K | 0.04% | 310 |
|
|
2024
Q3 | $355K | Sell |
5,374
-1,421
| -21% | -$93.8K | 0.03% | 389 |
|
|
2024
Q2 | $628K | Buy |
6,795
+6,774
| +32,257% | +$626K | 0.04% | 295 |
|
|
2024
Q1 | $2.01K | Hold |
21
| – | – | ﹤0.01% | 284 |
|
|
2023
Q4 | $1.6K | Buy |
+21
| New | +$1.6K | ﹤0.01% | 279 |
|